LACEY STEINWAND: Open Payments
NPI 1427710276 · LEWISTON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 48 payments from 9 companies in 2025. Trend: 2023 $790 · 2024 $1,302 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $236 |
| AstraZeneca Pharmaceuticals LP | 4 | $234 |
| ABBVIE INC. | 10 | $163 |
| GlaxoSmithKline, LLC. | 7 | $121 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Novo Nordisk Inc | 1 | $24 |
| Amgen Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $14 |
Products named: AIRSUPRA, NURTEC ODT, TRELEGY ELLIPTA, UBRELVY, ELIQUIS, AUSTEDO XR, QULIPTA, Auvelity.
Industry payments across ID — which companies pay providers there.
